SurpassMD vs Henry Meds: GLP-1 Pricing & Programs Compared
SurpassMD and Henry Meds both sell compounded GLP-1 weight loss programs online, but they compete on different axes: SurpassMD on flat, low pricing (semaglutide as low as $114/month, tirzepatide as low as $177/month, with no increase as your dose rises), 48-hour shipping, and a needle-free oral semaglutide option; Henry Meds on oral tirzepatide tablets and consultation depth. Here is the full comparison.
Side-by-Side Comparison (July 2026)
| Feature | SurpassMD | Henry Meds |
|---|---|---|
| Semaglutide (injectable) | As low as $114/mo | $297/mo (low dose), $397 (high) |
| Semaglutide (oral) | Available (needle-free) | $249-349/mo (tablets/drops) |
| Tirzepatide | As low as $177/mo (injectable) | $349-449/mo (oral tablets) |
| Oral tirzepatide | Not offered | Yes — key differentiator |
| Dose escalation | Flat — no increase with dose | +~$100/mo per tier above 1mg |
| Prepay discounts | Flat low price without prepay | 6-mo ~$247/mo |
| Shipping | Cold, within 48 hours | 3-5 business days |
| Consultation style | Async provider review | 30-45 min consult |
| Coaching | Nutrition guidance included | Premium coaching $50-100/mo extra |
| Payment | Cash-pay; HSA/FSA & Klarna | Cash-pay focus; brand-name possible at much higher cost |
| Coverage | 50 states + DC | Most states |
| Track record | New brand (2026) | Established, multi-year track record |
Where the Price Gap Comes From
The $173/month gap on semaglutide is the headline, but the structural difference is dose-tier pricing. Henry Meds adds roughly $100/month per tier above 1mg, so a patient reaching a common maintenance dose can pay $397/month by month six. SurpassMD, by contrast, is flat-priced: its as-low-as $114/month semaglutide rate does not rise with dose, so the maintenance dose costs the same as the starting dose. Henry's 6-month prepay closes some of the gap but requires committing upfront.
Henry Meds' genuine edge is form factor: it is one of the only major platforms with oral tirzepatide tablets, which matters for needle-averse patients who want the stronger dual-agonist molecule. See our oral tirzepatide guide for the bioavailability trade-offs.
Verdict: Which Should You Choose?
On price, shipping, and injectable options, SurpassMD leads this matchup. On oral tirzepatide, consultation length, and brand maturity, Henry Meds does. Price-sensitive patients starting injectable semaglutide or tirzepatide have little reason to pay Henry's premium; needle-averse patients set on tirzepatide have little alternative to it.
Full reviews: SurpassMD review and Henry Meds review. Compare the whole field in best GLP-1 telehealth providers and the full price comparison.
Frequently Asked Questions
SurpassMD, by a wide margin: compounded semaglutide as low as $114/month, flat across every dose, versus $297/month for injectable compounded semaglutide at Henry Meds as of July 2026. Henry Meds narrows the gap with prepay plans (roughly $247/month effective on a 6-month commitment), and its advertised $179 rate applies to liraglutide, not semaglutide. At Henry Meds, doses above 1mg add about $100 per tier; SurpassMD stays flat regardless of dose.
Yes: oral tirzepatide tablets ($349-449/month), which SurpassMD does not carry — SurpassMD's oral option is needle-free semaglutide. Henry Meds also offers longer 30-45 minute consultations, which are its selling point. Patients who specifically want tirzepatide without injections have few alternatives to Henry Meds among major platforms.
SurpassMD ships cold within 48 hours of provider approval, to all 50 states plus DC. Henry Meds typically quotes 3-5 business days from prescription to delivery. Both ship compounded injectables cold-packed with tracking.
At Henry Meds, doses above 1mg semaglutide add roughly $100 per month per tier, so a patient titrating to a typical maintenance dose can pay substantially more than the starting rate by month six. SurpassMD is flat-priced: the as-low-as $114/month semaglutide and $177/month tirzepatide rates do not rise with dose, so your maintenance dose costs the same as your starting dose.
Both are digital health platforms that route intakes to independent licensed providers and fill prescriptions through licensed compounding pharmacies, and both are cash-pay models. Henry Meds is the more established brand with a multi-year public track record; SurpassMD is newer (2026) with a shorter one. At both, prescriptions are never guaranteed and compounded medications are not FDA-approved.
Choose SurpassMD if price and shipping speed drive the decision: flat pricing as low as $114/month semaglutide and $177/month tirzepatide that never rises with dose, 48-hour fulfillment, and a needle-free oral semaglutide option lead this matchup. Choose Henry Meds if you want oral tirzepatide tablets or its deeper 30-45 minute consultations and will pay the premium.
This page is informational and is not medical advice. SurpassMD is operated by Life Vitality LLC, which also owns Peptide Dossier. Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. Prescriptions are never guaranteed. Pricing verified July 2026 and subject to change.